Advertisement

Gastric Cancer

, Volume 10, Issue 3, pp 187–190 | Cite as

Experience of gastric cancer in a patient who had received a living-donor liver transplantation

  • Yasuhiro Nagata
  • Susumu Eguchi
  • Mitsuhisa Takatsuki
  • Akihito Enjoji
  • Tatsuki Ichikawa
  • Tomayoshi Hayashi
  • Takashi Kanematsu
Case report

Abstract

A 57-year-old woman had previously undergone a living-donor liver transplantation (LDLT) for end-stage liver disease related to hepatitis B virus. The liver graft had been donated by her husband. Her postoperative course had been uneventful. In the course of postoperative surveillance, she was incidentally found to have gastric cancer by an endoscopic examination 2 years after the liver transplantation. A gastric resection was the treatment choice, and the results were successful. The tumor, which was moderately differentiated adenocarcinoma, was limited to the mucosal layer, with no metastasis. In addition, a Helicobacter pylori infection was observed. This is the first reported case of a gastric cancer after LDLT. We report this case because of its importance regarding the need to carry out close surveillance in transplant recipients who are treated with immunosuppressive drugs, in order to make a timely identification of the occurrence of common malignancies.

Key words

Living-donor liver transplantation Gastric Cancer Helicobacter pylori 

References

  1. 1.
    Buell, JF, Gross, TG, Woodle, ES 2005Malignancy after transplantationTransplantation80S254264PubMedCrossRefGoogle Scholar
  2. 2.
    Buell, JF, Husted, T, Hanaway, MJ, Trofe, J, Gross, T, Beebe, T,  et al. 2002Gastric cancer in transplant recipients: detection of malignancy [correction of malignacy] by aggressive endoscopyTransplant Proc3417845PubMedCrossRefGoogle Scholar
  3. 3.
    Monden, M, Umeshita, K 2005Liver transplantation in Japan — Registry by the Japanese Liver Transplantation SocietyJpn J Transplantation4051826Google Scholar
  4. 4.
    Penn, I 2000Post-transplant malignancy: the role of immunosuppressionDrug Saf2310113PubMedCrossRefGoogle Scholar
  5. 5.
    Buell, JF, Husted, T, Hanaway, MJ, Peddi, VR, Trofe, J, Gross, TG,  et al. 2002Incidental diagnosis of gastric cancer in transplant recipients improves patient survivalSurgery1327548discussion 758–60PubMedCrossRefGoogle Scholar
  6. 6.
    Buell, JF, Beebe, TM, Hanaway, MJ, Thomas, MJ, Rudich, SM, Woodle, ES 2005Transplant-Related malignancyBusuttil, RWKlintmalm, GB eds. Transplantation of the liver. Second edW. B. SaundersPhiladelphia114964Google Scholar
  7. 7.
    Ikeda, H, Old, LJ, Schreiber, RD 2002The roles of IFN gamma in protection against tumor development and cancer immunoeditingCytokine Growth Factor Rev1395109PubMedCrossRefGoogle Scholar
  8. 8.
    Dunn, GP, Ikeda, H, Bruce, AT, Koebel, C, Uppaluri, R, Bui, J,  et al. 2005Interferon-gamma and cancer immunoeditingImmunol Res3223146PubMedCrossRefGoogle Scholar

Copyright information

© International and Japanese Gastric Cancer Association 2007

Authors and Affiliations

  • Yasuhiro Nagata
    • 1
  • Susumu Eguchi
    • 1
  • Mitsuhisa Takatsuki
    • 1
  • Akihito Enjoji
    • 1
  • Tatsuki Ichikawa
    • 2
  • Tomayoshi Hayashi
    • 3
  • Takashi Kanematsu
    • 1
  1. 1.Department of SurgeryNagasaki University Graduate School of Biomedical SciencesNagasakiJapan
  2. 2.First Department of Internal MedicineNagasaki University HospitalNagasakiJapan
  3. 3.Department of PathologyNagasaki University HospitalNagasakiJapan

Personalised recommendations